Bachem Holding company profile

BANB · SIX · CHF

Compare Bachem Holding
CHF 77.05Change from previous close: −2.84%Absolute change: −CHF 2.25

Close · November 17, 2026

Company profile

Bachem Holding has 2,725 employees and is headquartered in Bubendorf, Switzerland.

Pharmaceutical and biotech companies around the world rely on Bachem Holding AG, which develops and manufactures peptide active pharmaceutical ingredients. Its portfolio spans peptide and oligonucleotide new chemical entities, commercial new chemical entities and generics. Alongside production, the group provides project management, analytical services, quality and regulatory work, research-grade production and supply services.

In the fiscal year ended 31 December 2025, the group reported revenue of CHF 695.1 million, an increase of 14.8% on the previous year, and net income of CHF 148.8 million. The company has 2,725 employees, and its headquarters are in Bubendorf, Switzerland. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.

Company facts

Industry
Biotechnology
Headquarters
Hauptstrasse 144, 4416, Bubendorf
Employees
2,725
Chief executive
Anne-Kathrin Stoller
Founded
1971
Fiscal year
January - December
Listing
BANB · SIX
Currency
CHF
ISIN
CH1176493729
Website
bachem.com

Bachem Holding and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Bachem HoldingBANBSwitzerland$6.92B2,72521.8%39.2
ABIVAXABVXFrance$7.61B98-6,270.4%—
ALK-AbellóALK.BDenmark$8.09B2,77326.9%40.7
CamurusCAMXSweden$4.36B32337.4%58.5
Financière de TubizeTUBBelgium$11.78B30.0%109.0
BioArcticBIOA.BSweden$2.72B15019.6%262.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Bachem Holding with its competitors